Search

Your search keyword '"te SLAA, E."' showing total 23 results

Search Constraints

Start Over You searched for: Author "te SLAA, E." Remove constraint Author: "te SLAA, E."
23 results on '"te SLAA, E."'

Search Results

1. Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

2. Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

5. Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

9. Circulating tumor cells do not correspond with clinicopathological characteristics of muscle-invasive bladder cancer patients undergoing radical cystectomy: Interim results of the CirGuidance study

11. 955 ADDRESSING BARRIERS TO PATIENT ACCRUAL IN CLINICAL TRIALS: LESSONS FROM THE EORTC PROSTATE CANCER TRIAL 22043-30041

13. Urodynamic assessment in the laser treatment of benign prostatic enlargement

18. "Your brain can't wait": perspectives of children and adolescents with acquired brain injury and their parents on physical rehabilitation during the subacute phase.

19. Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography.

20. Laser treatment of the prostate using the Urolase fiber: the Dutch experience.

21. Variation in output power of laser prostatectomy fibers: a need for power measurements.

22. Lasers in the treatment of benign prostatic obstruction: past, present, and future.

23. Urodynamic assessment in the laser treatment of benign prostatic enlargement.

Catalog

Books, media, physical & digital resources